Innovation Areas in In-Vitro Diagnostics
Today, leaders and pioneers in IVD are partnering with Ipsos to accelerate advancements across several key innovation areas
The In-Vitro Diagnostics (IVD) landscape is undergoing a revolutionary transformation, fuelled by the advent of next-generation sequencing, biosensor development, digital health, wearable advancements, and not to forget, the COVID-19 pandemic.
Today, leaders and pioneers in IVD are partnering with Ipsos to accelerate advancements across several key innovation areas including genomics, point-of-care and at-home testing, advancements in multiplex testing, and the complimentary use of IVD alongside other diagnostic tools like imaging.
Our latest report takes a deep dive into the IVD innovation areas from a disease state perspective, identifying white space opportunities that could revolutionize the way we prevent, detect, and treat diseases. We're exploring established diagnostic categories and stretching the boundaries of IVD application to areas like oncology, neurology, emergency medicine, infectious disease, and DTC IVD.
Download our full report to dive into the exciting world of IVD innovations
